Valneva SE

Valneva SE is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical needs. Operating within the biotechnology and pharmaceutical sectors, Valneva leverages its expertise in vaccine development to address a range of global health challenges. The company's portfolio includes vaccines targeting diseases such as Lyme disease, chikungunya, and Japanese encephalitis, among others. Valneva is committed to advancing public health by providing innovative vaccine solutions to protect individuals from preventable infections. The company actively engages in research and development, clinical trials, and strategic partnerships to expand its product pipeline and global reach, aiming to improve the well-being of populations worldwide through effective immunization strategies. Valneva aims to be a leader in the specialty vaccine market.